Zenas BioPharma, Inc. Cash Flow Statement

Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -37.12M-161.35M
Depreciation and Depletion 0.11M0.14M
Share-based Compensation 3.50M10.82M
Gains from Sales and Divestitures 0.01M
Gains from Investment Securities 0.10M1.10M
Non-cash Items 8.08M1.29M
Cash from Operations -30.53M-119.67M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.60M
Depreciation & Amortization (CF) 0.11M0.14M
Change in Working Capital
Change in Account Payables -0.42M11.74M
Change in Accured Expenses -3.56M22.07M
Other Working Capital Changes 3.35M7.70M
Investing Activities
Capital Expenditures 0.02M0.13M
Change in Acquisitions & Divestments 6.00M
Cash from Investing Activities -0.02M-30.55M
Financing Activities
Other financing activities 6.33M
Cash from Financing Activities 20.12M412.96M
Additional items
Exchange Rate Effect 0.08M0.16M
Change in Cash -10.35M262.89M
Free Cash Flow -30.55M-119.81M
Net Cash Flow -10.43M262.73M